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 44 
Abstract 45 
Amino acid neurotransmitters in synaptic afferents to hypothalamic gonadotropin-releasing 46 
hormone-I (GnRH) neurons are critically involved in the neuroendocrine control of reproduction. 47 
While in rodents the major amino acid neurotransmitter in these afferents is GABA, 48 
glutamatergic axons also innervate GnRH neurons directly. Our aim with the present study was 49 
to address the relative contribution of GABAergic and glutamatergic axons to the afferent control 50 
of human GnRH neurons. Formalin-fixed hypothalamic samples were obtained from adult male 51 
individuals (n=8) at autopsies and their coronal sections processed for dual-label immunohistochemical 52 
studies. GABAergic axons were labeled with vesicular inhibitory amino acid transporter (VIAAT) 53 
antibodies, whereas glutamatergic axons were detected with antisera against the major vesicular 54 
glutamate transporter isoforms, VGLUT1 and VGLUT2. The relative incidences of GABAergic and 55 
glutamatergic axonal appositions to GnRH-immunoreactive neurons were compared quantitatively in two 56 
regions, the infundibular and paraventricular nuclei. Results showed that GABAergic axons established 57 
the most frequently encountered type of axo-somatic apposition. Glutamatergic contacts occurred in 58 
significantly lower numbers, with similar contributions by their VGLUT1 and VGLUT2 subclasses. The 59 
innervation pattern was different on GnRH dendrites where the combined incidence of glutamatergic 60 
(VGLUT1+VGLUT2) contacts slightly exceeded that of the GABAergic appositions. We conclude that 61 
GABA represents the major amino acid neurotransmitter in axo-somatic afferents to human 62 
GnRH neurons, whereas glutamatergic inputs occur somewhat more frequently than GABAergic 63 
inputs on GnRH dendrites. Unlike in rats, the GnRH system of the human receives innervation 64 
from the VGLUT1, in addition to the VGLUT2, subclass of glutamatergic neurons.  65 
  66 
67 
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Introduction 68 
 Projections of type I gonadotropin-releasing hormone (GnRH) synthesizing neurons to the 69 
pericapillary space of the hypophysial portal blood vasculature represent the final common output way of 70 
the hypothalamus in the neuroendocrine control of reproduction (1). The neurosecretory activity of 71 
GnRH neurons is regulated by a variety of neurotransmitters/neuromodulators (2), which include the 72 
dominant inhibitory and excitatory amino acid neurotransmitters of the hypothalamus, γ-aminobutyric 73 
acid (GABA) and L-glutamate, respectively (3, 4). 74 
 Evidence mostly from studies of laboratory rodents indicates that GABA exerts multiple central 75 
effects on the reproductive axis and represents the principal neurotransmitter in the synaptic control of 76 
GnRH neuronal functions (2). GnRH neurons receive an abundant synaptic input from GABAergic 77 
neurons (5) and express functional receptors for both ionotropic GABAA (6-8) and metabotropic GABAB 78 
(9) receptors. All GnRH neurons in mice exhibit GABAA receptor mediated postsynaptic currents (7, 8). 79 
The putative importance of GABA in the afferent control of human GnRH neurons requires clarification.  80 
 In addition to GABA, the major excitatory amino acid neurotransmitter L-glutamate is also critically 81 
involved in the hypothalamic control of the reproductive axis (2), via regulating the onset of puberty (10) 82 
and the pulse (11) and surge (12) modes of GnRH secretion. In laboratory rodents, at least some of the 83 
glutamatergic actions are exerted directly on GnRH neurons which express ionotropic receptors for 84 
glutamate (6, 13, 14) and exhibit spontaneous excitatory postsynaptic currents that are mostly mediated 85 
by AMPA receptors (15, 16). Prior to exocytotic release, glutamate is accumulated into synaptic vesicles 86 
by one of the three distinct subtypes of vesicular glutamate transporters (VGLUT1-3), out of which 87 
VGLUT2 represents the dominant isoform in the rodent hypothalamus. In rats, glutamatergic fibers 88 
expressing VGLUT2 account for most of the glutamatergic innervation of hypothalamic neuroendocrine 89 
cells (17, 18). Specifically, glutamatergic neurons of the VGLUT2, but not the VGLUT1, phenotype 90 
innervate GnRH cells, with terminals preferentially targeting the dendritic compartment (17). The 91 
  
      
4  
relative abundances of the VGLUT1 and VGLUT2 isoforms in the human hypothalamus and their 92 
contribution to a putative glutamatergic input to GnRH neurons have not been addressed yet. 93 
 In the present study we used dual-label immunohistochemistry to visualize GABAergic afferents and 94 
glutamatergic afferents to GnRH neurons of the human hypothalamus. GABAergic terminals were 95 
detected with a primary antiserum directed against the vesicular inhibitory amino acid transporter 96 
(VIAAT)(19), whereas two distinct subclasses of glutamatergic terminals were detected with VGLUT1 97 
and VGLUT2 antisera, respectively. A quantitative light microscopic analysis was carried out separately 98 
in the infundibular (Inf) and paraventricular nuclei (Pa), to determine the relative abundances of 99 
GABAergic and glutamatergic neuronal contacts onto GnRH-immunoreactive (IR) cell bodies and 100 
dendrites as well as the relative incidences of VGLUT1-IR vs. VGLUT2-IR glutamatergic contacts. 101 
 102 
Materials and methods 103 
Human subjects 104 
Human hypothalamic samples from eight male individuals (between 30 and 70 years of age) were 105 
collected from autopsies at the Forensic Medicine Department of the University of Debrecen with 106 
permission from the Regional Committee of Science and Research Ethics of the University of Debrecen 107 
(DEOEC RKEB/IKEB: 3183-2010). Selection criteria included sudden causes of death, lack of history of 108 
neurological and endocrine disorders. Post mortem delay was kept below 36h.  109 
Section preparation  110 
Following dissection, the hypothalamic tissue blocks were rinsed briefly with running tap water and 111 
then, immersion-fixed with 4% formaldehyde in 0.1M phosphate buffer saline (PBS; pH 7.4) for 7 days 112 
at 4°C. Following fixation, the blocks were trimmed further to include the optic chiasma rostrally, the 113 
mammillary bodies caudally and the anterior commissure dorsally (20). Bilateral sagittal cuts were made 114 
2cm lateral from the midline. The blocks were finally bisected and then, infiltrated with 20% sucrose for 115 
5 days at 4°C. The right hemihypothalami were placed in a freezing mold, surrounded with Jung tissue 116 
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freezing medium (Leica Microsystems, Nussloch Gmbh, Germany; diluted 1:1 with 0.9% sodium 117 
chloride solution), snap-frozen on powdered dry ice, and sectioned coronally at 30μm with a Leica SM 118 
2000R freezing microtome (Leica Microsystems). 119 
Pretreatments 120 
The tissues were permeabilized and endogenous peroxidase activity reduced using a mixture of 0.2% 121 
Triton X-100 and 0.5% H2O2 in PBS for 30 min. Antigen epitopes were unmasked by antigen retrieval 122 
using a 0.1M citrate buffer (pH 6.0) treatment at 80 °C for 30 min.  123 
Immunohistochemical detection of VIAAT-, VGLUT1- or VGLUT2-IR fibers 124 
To detect GABAergic terminals, every 60th section from each block was incubated in polyclonal 125 
antisera against VIAAT for 48 h at 4°C. Another two series of sections were used similarly to visualize 126 
VGLUT1 and VGLUT2 immunoreactivities, respectively. As described previously (21, 22), the affinity-127 
purified primary antibodies were raised in goats against GST-fusion constructs, which included 128 
mouseVIAAT (aa 31-112), mouseVGLUT1 (aa 531-560) and mouseVGLUT2 (aa 559-582) sequences. 129 
The antibodies were diluted at 1:2000 in normal horse serum (NHS) and reacted sequentially with biotin-130 
SP-antigoat IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA; 1:500) and the ABC 131 
Elite reagent (Vector Laboratories, Burlingame, CA, USA; 1:1000) for 60 min each. The peroxidase 132 
signal was visualized with nickel-intensified diaminobenzidine chromogen and then, post-intensified with 133 
silver-gold (23).  134 
Specificity control experiments either used primary antibodies that were preabsorbed with 1µg/ml of 135 
the relevant immunization antigen or immunohistochemical procedures from which the primary antibody 136 
step was omitted. Positive control experiments used a different set of primary antibodies against GST-137 
fusion constructs of the three vesicular transporters: guinea pig anti-mouseVIAAT (N82; aa 31-112; 138 
1:2000), rabbit anti-mouseVGLUT1 (C30; aa 531-560; 1:2000) and mouse anti-humanVGLUT2 (aa 542-139 
582; #228; 1:8000). As described for the goat primary antisera, these control antibodies were reacted 140 
with appropriate biotinylated secondary antibodies (Jackson ImmunoResearch) and then, with the ABC 141 
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reagent. Finally, the peroxidase reaction was developed using the silver-gold intensified nickel-142 
diaminobenzidine chromogen.  143 
Detection of GnRH neurons 144 
Following the visualization of amino acidergic fibers with the black silver-gold-intensified nickel-145 
diaminobenzidine chromogen, GnRH immunoreactivity was detected. First, the sections were incubated 146 
overnight with a guinea pig primary antiserum against the mammalian form of GnRH (GnRH-I; #1018; 147 
1:5000), followed by biotin-SP-antiguinea pig IgG (Jackson ImmunoResearch Laboratories; 1:500) and 148 
the ABC Elite reagent (1:1000). The peroxidase signal was developed with the brown diaminobenzidine 149 
chromogen. For characterization and specificity testing of this guinea pig GnRH antiserum, see (24). 150 
Section mounting and coverslipping  151 
The dual-immunolabeled sections were mounted on microscope slides from Elvanol, air-dried, 152 
dehydrated with 95% (5 min), followed by 100% (2X5 min) ethanol, cleared with xylene (2X5 min) and 153 
coverslipped with DPX mounting medium (Fluka Chemie; Buchs, Switzerland). The microscopic images 154 
were scanned with an AxioCam MRc 5 digital camera mounted on a Zeiss AxioImager M1 microscope 155 
using the AxioVision 4.6 software (Carl Zeiss, Göttingen, Germany).  156 
Quantitative analysis of axo-somatic and axo-dendritic neuronal contacts   157 
One-to-three sections per double-labeling experiment were selected from each human subject to 158 
determine the number of axo-somatic and axo-dendritic contacts on GnRH neurons. To take into account 159 
the dendrites and exclude the axons of GnRH neurons, the analysis was restricted to GnRH-IR fibers that 160 
exhibited a non-varicose appearance. 161 
The regional density of GABAergic and glutamatergic fibers was highly variable which could cause 162 
region-specific differences in the innervation pattern of GnRH neurons. Therefore, the quantitative 163 
analysis of contacts was carried out separately in two regions where sufficient numbers of GnRH neurons 164 
could be analyzed, the Inf and the Pa. The sections were coded and randomized from the three double-165 
labeling experiments. Counting was carried out using a 63X oil-immersion objective. A contact was 166 
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defined using stringent criteria that were applied consistently, i.e. the axon and the GnRH-IR profile had 167 
to be in the same focus plane without any visible intervening gap (24-27). For each subject and region, 168 
the mean number of contacts per GnRH soma and the mean number of contacts per 10µm GnRH dendrite 169 
were determined. Counts obtained from the Inf and the Pa were expressed as the mean of 5-8 individuals, 170 
for each of the three types of labeling. The relative abundances of VIAAT/GnRH, VGLUT1/GnRH and 171 
VGLUT2/GnRH contacts as well as putative region-dependent variations in the incidences of the 172 
different types of input were compared statistically by one-way ANOVA, followed by Newman-Keuls 173 
post hoc test.  174 
Double-labeling fluorescent immunohistochemistry  175 
To demonstrate neuronal appositions in confocal images, a set of sections was treated with a mixture 176 
of 0.5% H2O2 and 0.2% Triton X-100 for 30 min. To reduce tissue autofluorescence caused by neuronal 177 
lipofuscin deposits, the sections were pretreated with Sudan black (24). For immunofluorescent labeling, 178 
the sections were incubated in the goat anti-VIAAT, anti-VGLUT1 or anti-VGLUT2 antisera (diluted at 179 
1:2000 with 2% NHS in PBS) for 48h at 4°C, then, in biotin-SP-antigoat IgG (Jackson ImmunoResearch 180 
Laboratories; 1:500) for 60 min and in ABC Elite reagent (Vector Laboratories; 1:1000) for 60 min. 181 
Then, biotinylated tyramide was deposited on peroxidase-containing sites according to the 182 
manufacturer’s instructions (TSA kit; NEN Life Science Products, Boston, MA). Biotin-tyramide 183 
deposits were finally reacted with Cy3-conjugated-streptavidin (Jackson ImmunoResearch; 1:1000) for 184 
60 min. Subsequently, immunoreactivity for GnRH was detected using the guinea pig GnRH antiserum 185 
(1:5000; 48h) which was reacted with FITC-conjugated donkey anti-guinea pig IgG (Jackson 186 
ImmunoResearch; 1:250; 2h). Photographic illustrations were prepared with a Radiance 2100 confocal 187 
microscope (Bio-Rad Laboratories, Hemel Hempstead, UK) using laser excitation lines 488 nm for FITC 188 
and 543 nm for Cy3 and dichroic/emission filters 560 nm/500–530 nm for FITC and 560–610 nm for 189 
Cy3. To eliminate emission cross-talk, single optical slices were collected in “lambda strobing” mode in 190 
a way that only one excitation laser and the corresponding emission detector were active during a line 191 
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scan. The digital images were processed with the Adobe Photoshop CS software (Adobe Systems, San 192 
José, CA, USA) at a resolution of 300 dpi. Brightness and contrast were adjusted when needed. Neuronal 193 
appositions were illustrated on single 0.7µm optical slices.   194 
 195 
Results 196 
The immunohistochemical detection of VIAAT, VGLUT1 and VGLUT2 revealed differentially 197 
patterned signals which reached varying intensity levels within distinct hypothalamic nuclei (Fig. 1). The 198 
punctate appearance of the immunoreactive fibers was characteristic of the subcellular distribution of 199 
small clear vesicles within amino acidergic axon terminals. Examples for the varying regional densities 200 
of the three types of signal in the infundibular (Inf), ventromedial (VMH), supraoptic (SO) and 201 
paraventricular (Pa) nuclei are illustrated in Figure 1. Control experiments showed the absence of 202 
labeling if primary antibodies were either omitted from the immunohistochemical procedure or 203 
substituted with working dilutions that also contained 1µg/ml of the immunization antigens (Figs. 2D-F). 204 
In addition, very similar labeling patterns could be obtained with the use of a different set of primary 205 
antisera as positive controls (compare lower to upper panels in Fig. 2), in further support of specificity.  206 
The immunohistochemical detection of GnRH revealed a few cell bodies and dendrites per section 207 
that were scattered over large areas in the human hypothalamus. To eliminate area-dependent variations, 208 
the comparative analysis of the different types of amino acidergic inputs to GnRH neurons was carried 209 
out region-specifically in two distinct hypothalamic nuclei, the Inf and the Pa. The most dense input to 210 
GnRH neurons of the Inf was by VIAAT-IR axons. These fibers formed numerous contacts onto the cell 211 
bodies and dendrites of GnRH-IR neurons (Fig. 3A). Glutamatergic axons of both the VGLUT1 (Figs. 212 
3C, D) and VGLUT2 (Figs. 3E, F) phenotypes were also juxtaposed to GnRH neurons. Overall, both the 213 
VGLUT1-IR and the VGLUT2-IR innervation appeared less heavy, compared with the VIAAT-IR input. 214 
Confocal microscopic analysis of dual-immunofluorescent specimens confirmed that GnRH neurons 215 
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receive VIAAT-IR and glutamatergic afferent inputs, without visible gaps between the juxtaposed 216 
neuronal profiles (Figs. 3B, G).  217 
The quantitative analysis of neuronal contacts onto GnRH cell bodies of the Inf revealed that the 218 
mean incidence of axo-somatic contacts (contacts/perikaryon) was 72.4% lower in case of VGLUT1 and 219 
59.8% lower in case of VGLUT2 than the incidence of VIAAT-IR contacts. These differences were 220 
statistically significant by one-way ANOVA, followed by Newman-Keuls test (VGLUT1 vs. VIAAT: 221 
P=0.003; VGLUT2 vs. VIAAT: P=0.009; Fig. 4A). The mean incidence of VGLUT2-IR contacts was 222 
somewhat higher compared with the mean incidence of VGLUT1-IR appositions, but statistical 223 
difference was not detected (P=0.35).  224 
The most frequently encountered phenotype of axo-dendritic appositions in the Inf (No of 225 
contacts/10µm GnRH dendrite length) was also established by VIAAT-IR fibers. Although VGLUT1-IR 226 
contacts were less frequent by 57.8% and VGLUT2-IR contacts by 33.5% than the VIAAT-IR 227 
appositions, their combined incidence on GnRH dendrites exceeded that of the VIAAT-IR axo-dendritic 228 
inputs by 8.6% (Fig. 4B). No obvious age-dependence could be revealed in the number of axo-somatic or 229 
axo-dendritic contacts with regression analysis. 230 
The relative abundances of different inputs to GnRH neurons of the Pa (Figs. 5A and B) showed 231 
identical tendencies to those described for the Inf (Figs. 4A and B). The following statistically significant 232 
differences were identified: axo-somatic VGLUT1 vs. VIAAT: P=0.0006; axo-somatic VGLUT2 vs. 233 
VIAAT: P=0.002; axo-dendritic VGLUT1 vs. VIAAT: P=0.04. 234 
Comparison of the incidences of axo-somatic and axo-dendritic inputs in the two regions has not 235 
revealed any significant regional difference between the innervation patterns of GnRH neurons in the Inf 236 
and the Pa. 237 
 238 
Discussion 239 
GABAergic regulation of human GnRH neurons 240 
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 As reviewed recently (28), a large body of evidence mainly obtained from rodents indicates that 241 
GABA influences many aspects of GnRH neuronal functions. In its direct actions on GnRH neurons, the 242 
dominant effects appear to be mediated by postsynaptic GABAA receptors which are ligand-gated ion 243 
channels composed of five subunits (29). Functional GABAA receptors have also been detected in GnRH 244 
neurons (6, 7). The modulation of GABAA receptor mediated synaptic transmission to GnRH neurons has 245 
been implicated in metabolic (8), sex steroid (30) and circadian (31) signaling to GnRH neurons. A long 246 
lasting debate reviewed recently (28) now appears to end with the consensus view that the dominant 247 
effect of GABAA receptor mediated neurotransmission to GnRH neurons is excitatory in mice and rats (7, 248 
32) which is explained by the sustained high intracellular chloride concentration of adult GnRH neurons. 249 
In view that in rodents, GnRH neuron activity is increased by both GABA and glutamate, retrograde 250 
endocannabinoid signaling may represent an important regulatory mechanism under physiological and 251 
pathological conditions whereby GnRH neurons in mice regulate their excitatory GABAergic inputs (33). 252 
In addition, GABA can also reduce the excitability of GnRH neurons via metabotropic GABAB receptors 253 
which activate an inwardly rectifying K+ current (34). It will require clarification to what extent the 254 
above electrophysiological observations allow us to conclude about the GABAergic mechanisms of 255 
action upon the primate GnRH neuronal system.   256 
 It is likely that VGAT-IR afferents innervating human GnRH neurons arise from multiple sources. In 257 
the absence of literature about the amino acid phenotype of human hypothalamic nuclei, it is difficult to 258 
speculate aboute these resources. The scattered distribution of human GnRH neurons (35) also raises the 259 
possibility that these sources are not the same at the different hypothalamic sites. In rodents, a 260 
considerable degree of segregation exists between hypothalamic GABAergic and glutamatergic cell 261 
groups (expressing glutamic acid decarboxylase and VGLUT2 mRNAs, respectively), as indicated by 262 
results of comparative in situ hybridization experiments (20). Many GABAergic systems afferent to 263 
GnRH neurons may exhibit an additional peptidergic neurotransmitter/neuromodulator phenotype. 264 
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Accordingly, peptidergic neurons co-synthesizing neuropeptide Y with agouti-related protein establish 265 
symmetrical synapses with murine GnRH neurons which is indicative of GABAergic neurotransmission 266 
(25). The abundant innervation of human GnRH neurons by neuropeptide Y-IR fibers (35) may be partly 267 
analoguous to this afferent system arising from the rodent arcuate nucleus. In mice, positive estrogen 268 
feedback is exerted in the anteroventral periventricular nucleus and neurons in this region partly use 269 
GABAergic mechanism for communication with GnRH neurons (36). A subset of GABAergic neurons at 270 
this site express kisspeptin mRNA (37) and a subset of kisspeptin-IR synapses on GnRH neurons exhibit 271 
symmetric morphology (38), suggesting use of combined GABAergic and peptidergic mechanisms in 272 
their communication with the GnRH system. Kisspeptin-immunoreactive neurons also innervate 273 
abundantly human GnRH neurons (24, 39), but their amino acid neurotransmitter phenotype is not 274 
known. A particularly interesting cell group in the anteroventral periventricular nucleus of the female rat 275 
contains glutamatergic as well as GABAergic markers. These GABA/glutamate dual-phenotype cells 276 
innervate GnRH neurons and exhibit sexual dimorphism and plastic chemotype changes at the time of the 277 
LH surge (40). Finally, we have to note that although VIAAT is a well-established marker for 278 
GABAergic cells (19), it also participates in vesicular packaging of glycine. We can not entirely rule out 279 
the possibility that some VIAAT-IR fibers we detected in the human hypothalamus are not GABAergic, 280 
but rather, ascend to the hypothalamus from a glycinergic cell group of the brainstem (41). However, the 281 
existence of a significant glycinergic input to GnRH neurons is unlikely given that, at least in mice, 282 
GABA and glutamate together account for the vast majority of fast synaptic currents recorded from 283 
GnRH neurons (15, 42).   284 
Glutamatergic innervation of GnRH neurons by VGLUT1 and VGLUT2-immunoreactive axons 285 
There is compelling evidence that the excitatory amino acid neurotransmitter L-glutamate plays a 286 
crucial role in the central regulation of reproduction via acting on the GnRH neurosecretory system. 287 
Accordingly, intravenous N-methyl-D,L-aspartate infusion can induce precocious puberty in immature 288 
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rats (10) and ionotropic glutamate receptor activation has been implicated in both the pulse (11) and the 289 
surge (12) modes of GnRH neurosecretion. Glutamate release into the preoptic area is increased during 290 
the LH surge (43, 44) and this increase is attenuated during reproductive aging (45). Conversely, 291 
inhibition of either the NMDA or the AMPA glutamate receptors is capable of blocking the LH surge 292 
(46, 47). Previous immunohistochemical evidence from laboratory rodents indicates that glutamate can 293 
regulate GnRH neurons at the level of GnRH cell bodies and dendrites in the preoptic area which receive 294 
VGLUT2-IR synapses (17, 18) and exhibit immunoreactivity for ionotropic glutamate receptors (14). In 295 
addition to acting postsynaptically, functional evidence indicates that glutamate can inhibit GABA 296 
release onto GnRH neurons via Group II and III metabotropic glutamate heteroreceptors that are present 297 
on GABAergic synaptic afferents (42).   298 
The current immunohistochemical study provides evidence that GnRH neurons in the human 299 
hypothalamus, similarly to rat GnRH neurons (17), receive direct VGLUT2-IR axo-somatic and axo-300 
dendritic inputs. Unlike rat GnRH neurons, GnRH neurons of the human Inf and Pa were also contacted 301 
by VGLUT1-IR afferents in our study. The mean incidence of these VGLUT1-IR contacts was only 302 
slightly lower compared with that of the VGLUT2-IR juxtapositions. The sources of glutamatergic inputs 303 
to GnRH cells are presently unclear. They can be of both hypothalamic and extrahypothalamic origins. 304 
The hypothalamus of the rat only contains glutamatergic neurons of the VGLUT2 phenotype (18). 305 
Provided that this is also the case in the human, VGLUT2-IR contacts on GnRH neurons can originate 306 
from both hypothalamic and extrahypothalamic excitatory neurons, whereas VGLUT1-IR contacts are 307 
more likely to arise exclusively from extrahypothalamic sources.  308 
Beyond the large body of evidence to support the role of glutamate in rodent reproduction, there is 309 
abundant literature to also indicate that glutamatergic mechanisms are involved in primate puberty onset 310 
(48) and GnRH secretion (49, 50). To our knowledge, our present study is the first to use the vesicular 311 
glutamate transporters as highly specific glutamatergic markers to analyze direct glutamate/GnRH 312 
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interactions in primate hypothalami. Early immunohistochemical work on monkeys with antibodies 313 
against glutamate provided evidence for immunoreactive glutamate in axon terminals that establish 314 
asymmetrical synapses with GnRH-IR neurons (51). The use of specific antisera against VGLUT1 and 315 
VGLUT2 provided us a tool to also distinguish between the two major subclasses of glutamatergic 316 
afferents to human GnRH neurons. Our analysis provided light microscopic evidence for VGLUT1-IR 317 
and VGLUT2-IR inputs to human GnRH cell bodies, in addition to GnRH dendrites. While the existence 318 
of this axo-somatic excitatory input is in accordance with the electron microscopic observation of 319 
VGLUT2-IR synapses on GnRH-IR cell bodies in rats (17), it is somewhat in conflict with previous 320 
immuno-electronmicroscopic results from Goldsmith and colleagues who found that excitatory inputs 321 
only target the dendritic compartment of GnRH neurons in monkeys (51). The different conclusion of 322 
these studies may result from potential species differences and/or the use of different 323 
immunohistochemical approaches and marker antigens.   324 
In addition to acting on GnRH neurons via afferent regulatory pathways, glutamate may also 325 
influence GnRH secretion via autocrine/paracrine mechanisms, as suggested by the presence of VGLUT2 326 
mRNA and immunoreactivity in GnRH neurons of the rat (52). In this rodent species, the endogenous 327 
glutamate which is likely released by GnRH neurons into the median eminence may act on the GnRH 328 
terminals which exhibit immunoreactivity for the KA2 and NR1 ionotropic glutamate receptor subunits 329 
(53), are apposed to glutamatergic axons (18, 53) and respond to glutamate and ionotropic glutamate 330 
receptor agonists with a Ca2+-dependent release of GnRH (53). As we reviewed recently (54), glutamate 331 
target cells may also include glutamate receptor expressing tanycytes and endothelial cells in the median 332 
eminence.  333 
While the primary goal of the present study was to analyze the amino acid neurotransmitters in 334 
neuronal afferents to the human GnRH neuronal system, the confocal analysis of dual-335 
immunofluorescent specimens also allowed us to address the presence of VGLUT2 immunoreactivity in 336 
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GnRH neurosecretory axon terminals targeting the postinfundibular eminence (55). In this study we have 337 
found no evidence for any VGLUT2 signal in GnRH-IR neurosecretory axons. This somewhat 338 
unexpected negative finding may suggest a species difference and raises the possibility that GnRH 339 
neurons in the human, unlike in the rat (52), do not express the glutamatergic marker VGLUT2. 340 
Alternatively, the colocalization of the two signals could have failed because of technical reasons. 341 
VGLUT2 expression might be of too low levels in human GnRH neurons to be detected with the 342 
immunofluorescent detection method. Electron microscopic studies provided evidence that VGLUT2 is 343 
localized to small-clear vesicles in the rat median eminence (56). It might be technically difficult to find 344 
GnRH-IR axon segments that co-contain small clear vesicles with VGLUT2 and large dense-core 345 
granules with GnRH. It is interesting to note that so far we have not been able to detect VGLUT2 346 
immunoreactivity in GnRH-IR axon terminals of the mouse median eminence either (unpublished 347 
observation), despite recent evidence for the VGLUT2 phenotype of mouse GnRH neurons from the 348 
VGLUT2-GFP transgenic mouse model (57).  349 
Relative incidences of GABAergic and glutamatergic appositions to human GnRH cells 350 
GnRH neurons in the human hypothalamus are distributed over a large area (35). To obtain an 351 
estimate about the relative importance of GABAergic and glutamatergic inputs to GnRH cells, we carried 352 
out a quantitative analysis of neuronal contacts at high-power. To eliminate regional variations, we have 353 
carried out the analysis of inputs separately in two hypothalamic nuclei, the Inf and the Pa. Although our 354 
results indicate that in these two regions the relative incidences of the three types of amino acidergic 355 
inputs are highly similar, the possibility exists that the innervation of GnRH neurons is different 356 
elsewhere in the human hypothalamus.    357 
Both in the Inf and the Pa, the VIAAT-IR axo-somatic appositions outnumbered the glutamatergic 358 
(VGLUT1-IR+VGLUT2-IR) axo-somatic appositions. This GABAergic dominance is in accordance with 359 
the electrophysiological observations on mice that GABAA receptor mediated postsynaptic currents 360 
  
      
15  
(PSCs) are present in all GnRH neurons (8), whereas glutamatergic excitatory PSCs are less abundant 361 
and only detectable in 20-35% of the GnRH cell bodies (15).  362 
The VIAAT-IR GABAergic appositions also represented the most frequently encountered type of 363 
axo-dendritic contact. However, the combined incidence of VGLUT1-IR+VGLUT2-IR inputs on the 364 
dendritic compartment somewhat exceeded that of the VIAAT-IR inputs (by 8.6% in the Inf and by 365 
26.3% in the Pa). This glutamatergic dominance on GnRH dendrites is in accordance with the general 366 
tendency of glutamatergic inputs to target dendrites and also with the specific observation on rats that 367 
VGLUT2-IR axons preferentially innervate the dendritic compartment of GnRH neurons (17). Although 368 
excitatory PSCs generated by these dendritic inputs might be undetectable in GnRH cell bodies using 369 
whole-cell patch-clamp electrophysiology (15), their physiological importance may still be crucial 370 
considering that most of the action potentials, at least in mice, appear to originate from the dendritic 371 
compartment of GnRH neurons (58). 372 
Technical considerations 373 
Some of the technical limitations of the quantitative analysis we used in the present study should be 374 
mentioned. First, recent three-dimensional reconstruction of biocytin-filled mouse GnRH neurons has 375 
provided evidence that the dendrites of GnRH neurons are much longer and their arborization richer than 376 
previously assumed from their immunohistochemical image (59). Therefore, it is important to emphasize 377 
that we had to restrict the quantitative analysis of inputs to the GnRH-IR dendritic segments that are 378 
relatively thick and close to GnRH cell bodies.  379 
Second, the approach of using the high-power light microscopic analysis of neuronal contacts, even 380 
with a shallow depth of field, has a somewhat limited capability to determine the absolute number of 381 
glutamatergic and GABAergic afferent inputs to GnRH neurons. Some appositions on top and below the 382 
GnRH neurons might remain undetected, causing false negatives. On the other hand, many light 383 
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microscopic contacts might be devoid of synaptic specializations at the electron microscopic level, which 384 
would cause false positive counts in the quantification. Even with these limitations, we argue that such 385 
quantitative studies are capable of providing an estimate of the relative ratios of VIAAT-IR, VGLUT1-IR 386 
and VGLUT2-IR inputs if the analysis relies on the use of randomized samples and consistent 387 
judgements by an experienced investigator who is blind to the applied immunohistochemical procedures. 388 
Clear trends and statistically significant differences in our quantitative results, as well as earlier 389 
quantitative studies using successfully a similar approach (24-27), confirm the feasibility and value of 390 
such analyses. 391 
In summary, in this study we show that GABAergic axons expressing VIAAT immunoreactivity and 392 
glutamatergic axons of both the VGLUT1 and VGLUT2 phenotypes abundantly innervate both the 393 
somatic and dendritic compartments of human GnRH neurons. We report the dominance of GABAergic 394 
over glutamatergic inputs to GnRH-IR somata in the Inf as well as the Pa. This finding is in accordance 395 
with published observations on mouse GnRH neurons about the dominance of GABAergic over 396 
glutamatergic miniature postsynaptic currents. As opposed to the somatic compartment of GnRH 397 
neurons, the dendrites received somewhat more glutamatergic (VGLUT1+VGLUT2) than GABAergic 398 
inputs. This excitatory afferentation may have an important contribution to the generation of action 399 
potentials which, at least in mice (58), tend to originate from the dendritic compartment of GnRH 400 
neurons.  401 
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 408 
Legends  409 
 410 
Figure 1. Identification of GABAergic and glutamatergic fibers in different hypothalamic nuclei. 411 
Most hypothalamic sites receive GABAergic innervation (immunoreactive to VIAAT; A, D, G, J) as well 412 
as glutamatergic innervation of both the VGLUT1 (B, E, H, K) and VGLUT2 (C, F, I, L) phenotypes. 413 
Note that the fine punctate appearance of the immunohistochemical signals (silver-gold intensified Ni-414 
DAB chromogen) is in accordance with the accumulation of the vesicular neurotransmitter transporters in 415 
small synaptic vesicles within amino acidergic axon terminals. The differential distribution of the three 416 
types of fibers in distinct anatomical regions is illustrated from the hypothalamic infundibular (Inf; A-C), 417 
ventromedial (VMH; D-F), supraoptic (SO; G-I) and paraventricular (Pa; J-L) nuclei. Scale bar=50μm.  418 
419 
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Figure 2. Results of specificity testing for the goat VIAAT, VGLUT1 and VGLUT2 antisera 420 
In preabsorption experiments, 1:2000 working dilutions of the goat VIAAT, VGLUT1 and VGLUT2 421 
antisera were preincubated overnight with 1µg/ml of the fusion proteins used to generate the antisera. 422 
Test sections with (D-F) and without (A-C) preabsorption were processed in parallel. Note the complete 423 
abolishment of immunohistochemical labeling using the preabsorbed primary antibodies (D-F) in 424 
representative test sections of the infundibular (Inf) and ventromedial (VMH) hypothalamic nuclei. 425 
Additional test experiments used three different polyclonal antibodies on neighboring sections as positive 426 
controls. The punctate immunolabeling obtained with the guinea pig anti-mouseVIAAT (N82; G), rabbit 427 
anti-mouseVGLUT1 (C30; H) and mouse anti-humanVGLUT2 (#228; I) antibodies are highly 428 
reminiscent to those obtained with the goat polyclonal antibodies (A-C). Scale bar=100μm.    429 
 430 
Figure 3. Demonstration of GABAergic and glutamatergic inputs to GnRH-IR neurons of the 431 
infundibular nucleus. 432 
Arrows in dual-immunohistochemical (A, C-F) and dual-immunofluorescent (B, G) images illustrate the 433 
axo-somatic and axo-dendritic contacts of VIAAT-IR GABAergic (A, B) and the VGLUT1-IR (C, D) 434 
and VGLUT2-IR (E-G) subclassess of glutamatergic axons to GnRH neurons of the infundibular nucleus 435 
(Inf). Note that the most dense innervation to GnRH perikarya is provided by GABAergic fibers, whereas 436 
glutamatergic fibers of both the VGLUT1 and VGLUT2 phenotypes also contribute substantially. Note 437 
that the dendrites of GnRH-IR neurons in lower part of panel D can be readily distinguished form GnRH-438 
IR axons (upper part of panel D), the latter exhibiting numerous varicosities (arrowheads) interconnected 439 
by thin intervaricose axon segments. The dendrites of GnRH neurons receive GABAergic and 440 
glutamatergic (combined VGLUT1 and VGLUT2) inputs in similar numbers. For quantitative analysis of 441 
the three types of input in the infundibular and paraventricular nuclei, see Figures 4 and 5, respectively. 442 
A confocal image of the infundibular stalk (InfS) from dual-immunofluorescent specimens (H) illustrates 443 
the segregation between GnRH-IR (green puncta) and VGLUT2-IR (red puncta) fibers around the 444 
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putative portal blood vessels (BV). Note the conspicuous accumulation of VGLUT2-IR fibers around the 445 
superficial network of portal capillaries (55). Unlike observed previously in the median eminence of rats 446 
(52), GnRH-IR fibers appear to be devoid of any VGLUT2 labeling in the 0.7μm optical slice (I).  Scale 447 
bar=20μm in A-G, J and 300μm in H. 448 
449 
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 450 
Figure 4. Relative incidences of GABAergic (VIAAT) and glutamatergic (of the VGLUT1 and 451 
VGLUT2 phenotypes) neuronal appositions to the cell bodies and dendrites of GnRH neurons in 452 
the infundibular nucleus. 453 
High-power light microscopic analysis of dual-immunolabeled sections was used to determine the 454 
relative incidences of GABAergic and glutamatergic contacts onto the somata (A) and dendrites (B) of 455 
GnRH-IR neurons in the infundibular nucleus (Inf). The counts were obtained from 1-3 sections per 456 
subject and expressed as the mean of the 5-8 individuals ± SEM. Quantitative analysis of axo-somatic 457 
contacts established that the main input to the cell bodies of GnRH neurons is provided by VIAAT-IR 458 
GABAergic axons (A). Glutamatergic axons of both the VGLUT1 and VGLUT2 phenotypes also 459 
innervate GnRH-IR perikarya, although the mean incidences of these contacts are significantly lower and 460 
only reach 27.6% and 40.2%, respectively, of the incidence of VIAAT-IR contacts (**P<0.01 by 461 
ANOVA, followed by Newman-Keuls). The relative incidence of the three types of contacts on GnRH-IR 462 
dendrites (expressed as the mean number of contacts/10µm dendrite ± SEM of 5-8 individuals; B) 463 
exhibits a similar trend, but glutamatergic inputs here have higher relative contributions (VGLUT1-IR 464 
inputs representing 42.2% and VGLUT2-IR inputs representing 66.5% of the VIAAT-IR contacts). The 465 
combined contribution of VGLUT1-IR and VGLUT2-IR inputs exceeds that of VIAAT-IR inputs by 466 
8.6%.  467 
468 
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Figure 5. Relative incidences of GABAergic and glutamatergic appositions to the cell bodies and 469 
dendrites of GnRH neurons in the paraventricular nucleus. 470 
High-power light microscopic analysis of neuronal contacts was also carried out in the paraventricular 471 
nucleus (Pa) to see if the innervation pattern is different in this region. The relative incidences of 472 
GABAergic and glutamatergic appositions to the somata (A) and dendrites (B) of GnRH-IR neurons 473 
show similar tendencies to those observed in the infundibular nucleus (Figure 4).  Quantitative analysis 474 
of axo-somatic contacts established that the main input to the cell bodies of GnRH neurons is provided 475 
by VIAAT-IR GABAergic axons (A). Glutamatergic axons of both the VGLUT1 and VGLUT2 476 
phenotypes also innervate GnRH-IR perikarya, although the mean incidence of their afferent contacts are 477 
significantly lower (29.8% and 46.6%, respectively, of the incidence of VIAAT-IR contacts; *P<0.05 and 478 
**P<0.01 by ANOVA, followed by Newman-Keuls. The incidence of the three types of contacts on 479 
GnRH-IR dendrites (expressed as the mean number of contacts/10µm dendrite ± SEM of 5-8 individuals; 480 
B) changes similarly, but glutamatergic inputs here have higher relative contributions (VGLUT1 input: 481 
57.0% of VIAAT-IR contacts; VGLUT2 input: 69.3% of VIAAT-IR contacts). The combined 482 
contribution of VGLUT1-IR and VGLUT2-IR inputs exceeds that of VIAAT-IR inputs by 26.3%.  483 
484 
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